Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer

被引:0
作者
Francisco J. Esteva
Stacy L. Moulder
Ana M. Gonzalez-Angulo
Joe Ensor
James L. Murray
Marjorie C. Green
Kimberly B. Koenig
Mong-Hong Lee
Gabriel N. Hortobagyi
Sai-Ching Yeung
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Breast Medical Oncology
[2] The University of Texas MD Anderson Cancer Center,Department of Biostatistics
[3] The University of Texas MD Anderson Cancer Center,Department of Molecular and Cellular Oncology
[4] The University of Texas MD Anderson Cancer Center,Department of Emergency Medicine
[5] The University of Texas MD Anderson Cancer Center,Department of Endocrine Neoplasia and Hormonal Disorders
来源
Cancer Chemotherapy and Pharmacology | 2013年 / 71卷
关键词
Breast neoplasm; Exemestane; Metformin; Rosiglitazone; Phase I trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:63 / 72
页数:9
相关论文
共 109 条
[1]  
Alimova IN(2009)Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro Cell Cycle 8 909-915
[2]  
Liu B(2005)Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice Exp Gerontol 40 685-693
[3]  
Fan Z(2009)Early breast cancer Lancet 373 1463-1479
[4]  
Anisimov VN(2008)Residual risk of breast cancer recurrence 5 years after adjuvant therapy J Natl Cancer Inst 100 1179-1183
[5]  
Berstein LM(2009)A liquid chromatography-tandem mass spectrometry method for the simultaneous determination of exemestane and its metabolite 17-dihydroexemestane in human plasma J Mass Spectrom 44 920-928
[6]  
Egormin PA(2008)Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib J Clin Oncol 26 1253-1259
[7]  
Benson JR(2002)Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells Breast Cancer Res Treat 74 155-165
[8]  
Jatoi I(2004)Monoclonal antibodies, small molecules, and vaccines in the treatment of breast cancer Oncologist 9 4-9
[9]  
Keisch M(2003)Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer J Clin Oncol 21 999-1006
[10]  
Brewster AM(1999)Locally advanced breast cancer Hematol Oncol Clin North Am 13 457-472